Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study

Human Gene Therapy

Volumn 8, Issue 5, 1997, Pages 615-624

  Tiberghien, P ^a   Cahn, J Y ^a   Brion, A ^a   Deconinck, E ^a   Racadot, E ^a   Herve, P ^a   Milpied, N ^a   Lioure, B ^a   Gluckman, E ^a   Bordigoni, P ^a   Jacob, W ^a   Chiang, Y ^a   Marcus, S ^a   Reynolds, C ^a   Longo, D ^a  

^a Laboratoire d'Histocompatibilite   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HUMAN; LEUKEMIA; LEUKOPENIA; MULTICENTER STUDY; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SUICIDE GENE; T LYMPHOCYTE; THROMBOCYTOPENIA; VIRUS GENE;

EID: 16944365744     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.5-615     Document Type: Article

References (31)

1. Gale RP: Graft-versus-host disease. Immunol Rev 88:193, 1985
2. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, Bekkum DWV, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120-2130, 1991
3. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New Engl J Med, 314:729-735, 1986
4. Horrowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562, 1990
5. Kernan NA, Barsch G, Ash DC, Beatty PG, Champlin R, Filipovich A, Gajewski, Hansen JA, Henslee-Downey J, McGullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blune KG. Analysis of 4162 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med, 328:593-602, 1993
6. Bowden RA: Infections in patients with graft-versus-host disease. In Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds): Graft-vs-Host disease: Immunology, Pathophysiology, and Treatment. Hematology/Volume 12, Marcel Dekker, Inc., New York, 1990, 525
7. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281, 1986.
8. Borrelli E, Heyman R, Hsi M, Evans RM. Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci, 85:7572-7576, 1986
9. Heyman RA, Borreli E, Lesley J, Anderson D, Richman DG, Baird SM, Hyman R, Evans RM. Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci, 86:2698-2702, 1989
10. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM, Contassot E, Murphy WJ, Lyons R, Chiang Y, Hervé P, Longo DL, Ruscetti FW. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T-lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84:1333-1341, 1994.
11. Miller AD, Buttimore C. Redesign of retrovirus packaging celle lines to avoid recombination leading to helper virus production. Mol Cell Biol, 6:2895-2902, 1986
12. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller D, Blaese M, Anderson F: Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl J Med 323:570-578, 1990
13. Brenner MK, Rill DR, Moen RC, Krahce RA, Mirro J, Anderson WF, Ihle JN. Gene-marking to trace the origin of relapse after autologous bone-marrow transplantation. Lancet 341:85-86, 1993
14. Fletcher C, Sawchuk R, Chinnock B, Miranda P, Balfour HH: Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther 40:281-285, 1986
15. Blaese RM, Culver KW, Dusty-Miller A, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Toltoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Jay-Ramsay W, Muul L, Morgan RA, French-Anderson W. T-lymphocyte directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475-480, 1995
16. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khourey A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bovren T, Hershfield MS, Mullen CA, Blaese RM, Parkman T. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine 1:1017-1023, 1995.
17. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470-475, 1995.
18. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Therapy 4:39-69, 1993
19. Racadot E, Hervé P, Beaujean F, Vernant JP, Flescg M, Plouvier E, Andreu G, Rio B, Philippe N, Souillet G, Pico J, Bordigoni JP, Ifrah N, Paitre ML, Lutz P, Morizet J, Bernard A. Prevention of graft-versus-host disease in HLA matched bone marrow transplantation for malignant disease; a multicentric study of 62 patients. J Clin Oncol, 5:426-435, 1987
20. Kernan NA, Collins NH, Juliano L, Caragena T, Dupont B, O'Reilly RJ. Clonable T lymphocytes in T cell depleted bone marrow transplants correlate with the development of GvHD. Blood, 75:776-780, 1990
21. Verdonck LF, De Gast GC, Van Heughton HG, Dekker AW. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood, 75:776-780, 1990
22. Slavin S, Nasparteck E, Nagler A, Ackerstein A, Kapelushnik Y, Drakos P, Or R. Graft vs leukemia (GVL) effects with controlled GVHD by cell mediated immunotherapy (CMI) following allogeneic bone marrow transplantation. Blood 84(suppl): 423a, 1994 (abstract)
23. Couriel D, Cottler-Fox M, Burt RK, Dunbar C, Hensel N, Yong NS, Barett AJ. T-cell depleted marrow transplantants with delayed lymphocyte add-back to prevent relapse in patients with leukemia. Blood 84 (suppl 1): 334a, 1994 (abstract)
24. Bonini C Verzeletti S, Servida P, Rossini S, Traversari C, Ferrari G, Nobili N, Mavilio F, Bordignon C. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo immunomodulation after allo-BMT. Blood 84 (suppl 1): 110a, 1994 (abstract)
25. Winston DJ, Gale RP. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation. Bone Marrow Transplantation, 8:7-11, 1991
26. Cornetta K, Nguyen N, Morgan R, Muenchau DD, Hartley JW, Blaese M, Anderson WF. Infection of human cells with murine replication-competent retrovirus. Human Gene Therapy, 4:579-588, 1993
27. Gunter KC, Khan AS, Noguchi PD. The safety of retroviral vectors. Human Gene Therapy, 4:643-654, 1993
28. Anderson WF, McGarrity G, Moen RC. Report to the NIH recombinant DNA advisory committee on murine replication-competent retrovirus assays. Human Gene Therapy 4:311-321, 1993
29. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW. Helper virus induced T cells in nonhuman primates after retroviral mediated gene transfer. J Exp Med, 176:1125-1135, 1993
30. Anderson WF. What about those monkeys that got T-cell lymphoma? Human Gene Therapy, 4:1-2, 1993
31. Davies J, Smith DI. Plasmid-determined resistance to anti-microbiol agents. Ann Rev Microbiol. 469-518, 1978